Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Prevention of Pseudomonas VAP
NCT00610623Phase 2Terminated
- Start
- Apr 2003
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of azithromycin in ventilator-associated pneumonia (VAP). Started Apr 2003; status: terminated.
02
Drugs
azithromycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00610623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610623.